Objective-To assess the possibility of maintaining ductal patency in neonates with complex pulmonary atresia by percutaneous implantation of balloon expandable stents.
Abstract
Objective-To assess the possibility of maintaining ductal patency in neonates with complex pulmonary atresia by percutaneous implantation of balloon expandable stents.
Patients-Two duct-dependent neonates with long segment pulmonary atresia, right sided aortic arch, and left sided arterial duct.
Results-Stents with final diameter of 3 5 or 4 mm and initial length of 7 or 15 mm were successfully positioned in the arterial duct. Two stents were required in one child and four in the other in order to stent the entire length of the duct. After the procedures the ducts remained widely patent and arterial oxygen saturations remained above 80%. Complications of the procedures included perforation of a peripheral pulmonary artery and cardiac perforation, both caused by guide wire manipulation. Both babies died suddenly, one at five weeks, and the other at nine days after successful stenting of the duct. Both ducts were patent at necropsy; the exact cause of one death was not clearly defined, but the second seemed to be caused by pneumococcal septicaemia.
Conclusions-Stenting of the arterial duct is technically feasible. It provides adequate palliation for neonates with pulmonary atresia at least in the short term and it seems to result in balanced, central perfusion of both pulmonary arteries. This angiography showed the duct to be widely patent and pulse oximetry showed an increase in peripheral oxygen saturation from 75% to 90%. The stent was not visible on radiographic screening, but this was not considered remarkable because the stent is rarely visible in adult coronary arteries. Treatment with prostaglandin E was stopped and the arteriotomy repaired.
After three hours the oxygen saturation fell to 40%. This did not improve after thrombolytic treatment but rose again to 85% when intravenous prostaglandin was restarted. Doppler colour flow mapping showed evidence of distal ductal stenosis which suggested that the implanted stent was too short. An attempt at changing to oral prostaglandin was unsuccessful.
Ten days later a second right axillary arteriotomy was performed and a 7 mm Johnson & Johnson stent was positioned in a similar manner in the distal duct uneventfully using a similar 4 mm balloon catheter (fig 2) . Angiography confirmed a very satisfactory stent position in the distal part of the duct, with the stent being just visible on screening and plainly visible on the plain chest radiograph on this occasion (fig 2) . The duct was widely patent and the arterial oxygen saturation had again risen to 90%. The child was returned to the intensive care unit, where 15 minutes later the oxygen saturation again fell to 40%, there was a fresh haemorrhage from the endotracheal tube and radiographic evidence of right upper lobe consolidation. The bleeding stopped without specific treatment but the next day oxygen saturation had not improved. Thrombolytic treatment did not cause any further haemorrhage but failed to produce any clinical improvement and prostaglandin E had little effect in the dose previously used successfully. Ultrasound examination proved unhelpful on this occasion. A repeat chest radiograph, however, showed the distal stent clearly, but the longer stent was still not visible in the proximal duct or in any other position in the vascular system. Retrospectively it became clear that the first stent had not, in fact, been deployed in the duct and had been pushed backwards off the balloon during the introduction of the balloon catheter, later to be unwittingly discarded inside the haemostatic valve.
The child improved with high dose intravenous prostaglandin E. His parents encouraged us to reattempt stenting of the proximal duct, and three days later the child was returned to the catheter laboratory where, through a left axillary artery cutdown, a 15 mm stent was easily positioned and expanded to 4 mm in the proximal duct overlapping the distal stent by 1-5-2 A 2-6 kg boy presented with cyanosis when he was two days old. He was the second of twins (his twin brother had coarctation of the aorta). Investigation showed him to have atrial isomerism, a complete atrioventricular septal defect, and long segment pulmonary atresia with confluent but small pulmonary arteries and with a right sided aortic arch and a left sided arterial duct supplying the pulmonary arteries. His parents wished to avoid surgical treatment and gave their informed consent to an attempt at stenting the arterial duct. Angiography via a right axillary artery cutdown and a 5F Van Andel sheath confirmed a right sided aortic arch with a long, curved, distally stenosed duct arising from the left side of the proximal aortic arch. The left subclavian artery arose anomalously from.the descending aorta. The arterial duct was cannulated with a 4F Cobra catheter, a 0-014 inch guide wire was positioned in the right lower lobe pulmonary artery, and a 7 mm long Johnson & Johnson stent was deployed in the distal duct through a 4 mm (3-3F) ACX Treatment was continued with dipyridamole, aspirin (15 mg/kg/day), and a heparin infusion to keep the activated partial thromboplastin time at 2-2-5 times the control value. The child remained well with arterial oxygen saturations above 80%. He was extubated the following day and anticoagulated with warfarirt, our initial plan being to continue this for eight weeks, when we expected that endothelialisation of the stent would be complete.
Ten days later he again became cyanosed. Repeat aortography via the right femoral artery showed very localised stenosis of the duct immediately at its junction with the pulmonary artery (fig 3) . A further 7 mm stent was delivered to this site and dilated to a diameter of 3-5 mm without difficulty, and with prompt improvement in oxygen saturation to 90%. At review eight days later the child was well and gaining weight. Pulse oximetry showed readings between 80% and 90% throughout the day. He was discharged home, where the following day he suffered two apnoeic episodes despite remaining pink and well. He suffered a further apnoeic episode on the way to hospital and resuscitation was unsuccessful. Necropsy showed that the duct was patent; there was asplenia and pneumococci were isolated from postmortem blood cultures. Three days later his twin brother was admitted to hospital after a near miss cot death at home.
Discussion
Although aortopulmonary shunt operations provide life-saving palliative treatment at low risk for neonates with pulmonary atresia, such surgical treatment has potential drawbacks. Both Blalock-Taussig (classical or modified) and Waterston shunts usually produce preferential blood flow to the pulmonary artery on the side of the shunt that can result in differential growth of the right and left pulmonary arteries. The Waterston anastomosis may be associated with distortion ofthe right pulmonary artery or pulmonary hypertension, and any kind of surgical intervention will inevitably result in scarring which may increase the risk of later, more definitive, surgical treatment. Non-surgical maintenance of ductal patency is therefore a highly desirable goal. Repeated procedures were required in both our cases because short sections of the arterial duct remained unstented. This was partly because we decided to stent the ducts in sections, sometimes using half length stents to maximise flexibility of the balloon catheter/ stent combination at tortuous sites. The most distal part of the duct seems to have remarkable powers to constrict even when only a few millimetres is left unstented. We now appreciate that great care has to be taken to ensure very accurate stent positioning at this end ofthe duct at an initial procedure if repeated visits to the catheter laboratory are to be avoided.
There was no clear cause of death in our first case, but as far as is possible to ascertain neither child died with inadequate pulmonary blood flow. The first child had apnoeic attacks in the immediate neonatal period which had been attributed to airway obstruction related to his extensive cleft palate and it is possible that this may have contributed to his death. His pulmonary blood flow seemed to be relatively high and he had required treatment with diuretics; left ventricular volume overload may also have contributed to his death. The second child had extremely complex congenital heart disease and asplenia. His death was almost certainly due to septicaemia, because pneumococci were grown from the postmortem blood culture. His twin brother's near miss cot death is also of note but of uncertain relevance. We are planning further detailed investigation of the ducts, including histological assessment of endothelialisation.
Further follow up and further experience in other patients with a wider variety of ductal anatomy is clearly required before medium term results of ductal stenting can be assessed. At least in the short term, however, this procedure seems to promise a non-surgical alternative to aortopulmonary shunt surgery, with the very attractive benefit of providing balanced perfusion of both lungs and therefore the potential of balanced growth of the pulmonary arteries.
